AHA Statement before the Senate Finance Committee on Prescription Drug Affordability and Innovation

AHA statement before the Senate Finance Committee on "Prescription Drug Affordability and Innovation: Addressing Challenges in Today’s Market."

Key Resources

Related Resources

Letter/Comment
AHA Comments on CMS Proposed Medicare Drug Pricing Model
Public
Advisory
CMS Finalizes Guidance on Implementation of the Medicare Drug Price Negotiation Program
Member
Testimony
AHA Statement on Legislative Proposals to be Considered Before Energy and Commerce Committee On Sept. 18
Public
Letter/Comment
AHA Letter to Reps. Fischbach and Pence Expressing Support of Congressional Review Act (CRA) Resolutions
Public
Infographics
Drug Prices and Shortages Increase Hospitals’ Costs and Jeopardize Patient Access to Care Infographic
AHA Center for Health Innovation Market Scan
3 Ways GLP-1 Drugs Could Impact Your Hospital’s Future